Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | %Female (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Energy Education Science and Technology Part A: Energy Science and Research (discontinued) | journal | 2.765 Q1 | 44 | 18 | 24 | 696 | 185 | 24 | 7.71 | 38.67 | 22.73 | |
2 | Current Cancer Drug Targets | journal | 2.236 Q1 | 103 | 86 | 225 | 5566 | 1105 | 214 | 4.88 | 64.72 | 37.24 | |
3 | Current Alzheimer Research | journal | 2.034 Q1 | 103 | 85 | 219 | 4077 | 1165 | 208 | 5.31 | 47.96 | 36.98 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 1.846 Q1 | 96 | 86 | 147 | 10049 | 656 | 130 | 3.62 | 116.85 | 48.67 | |
5 | Current Organic Synthesis | journal | 1.815 Q1 | 55 | 34 | 62 | 3569 | 258 | 61 | 4.10 | 104.97 | 25.00 | |
6 | Energy Education Science and Technology Part B: Social and Educational Studies (discontinued) | journal | 1.740 Q1 | 31 | 12 | 11 | 460 | 105 | 11 | 9.55 | 38.33 | 25.00 | |
7 | Current Medicinal Chemistry | journal | 1.700 Q1 | 202 | 289 | 800 | 38208 | 4319 | 799 | 5.25 | 132.21 | 37.80 | |
8 | Current Gene Therapy | journal | 1.672 Q1 | 80 | 47 | 127 | 4735 | 653 | 123 | 4.98 | 100.74 | 37.24 | |
9 | Current Pharmaceutical Design | journal | 1.657 Q1 | 183 | 409 | 1056 | 45111 | 4994 | 943 | 4.85 | 110.30 | 38.61 | |
10 | Current Protein and Peptide Science | journal | 1.604 Q1 | 96 | 73 | 147 | 6571 | 560 | 141 | 4.10 | 90.01 | 37.36 | |
11 | Open Ecology Journal | journal | 1.470 Q1 | 18 | 24 | 5 | 2003 | 13 | 5 | 2.60 | 83.46 | 25.61 | |
12 | Current Topics in Medicinal Chemistry | journal | 1.399 Q1 | 133 | 138 | 497 | 13860 | 1873 | 424 | 3.66 | 100.43 | 32.66 | |
13 | Current Organic Chemistry | journal | 1.360 Q1 | 112 | 157 | 305 | 16520 | 817 | 265 | 2.59 | 105.22 | 30.24 | |
14 | Current Drug Targets | journal | 1.356 Q1 | 119 | 159 | 397 | 17091 | 1370 | 355 | 3.09 | 107.49 | 38.14 | |
15 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.354 Q1 | 108 | 86 | 228 | 7351 | 984 | 208 | 4.00 | 85.48 | 41.47 | |
16 | Advances in Optical Technologies | journal | 1.304 Q1 | 29 | 17 | 37 | 513 | 82 | 35 | 2.22 | 30.18 | 13.89 | |
17 | Current Neuropharmacology | journal | 1.271 Q1 | 103 | 41 | 88 | 4630 | 324 | 85 | 3.46 | 112.93 | 32.79 | |
18 | Current Genomics | journal | 1.253 Q2 | 77 | 63 | 166 | 5957 | 465 | 163 | 2.86 | 94.56 | 41.33 | |
19 | Current Stem Cell Research and Therapy | journal | 1.182 Q1 | 63 | 52 | 95 | 4315 | 381 | 94 | 4.33 | 82.98 | 27.65 | |
20 | GeoArabia | journal | 1.166 Q1 | 63 | 28 | 79 | 1223 | 120 | 57 | 1.63 | 43.68 | 9.26 | |
21 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.156 Q1 | 52 | 20 | 72 | 2718 | 221 | 72 | 3.12 | 135.90 | 50.94 | |
22 | Current Drug Abuse Reviews | journal | 1.111 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
23 | Current Diabetes Reviews | journal | 1.047 Q2 | 68 | 45 | 111 | 3502 | 383 | 107 | 3.81 | 77.82 | 32.64 | |
24 | Current Vascular Pharmacology | journal | 1.040 Q1 | 69 | 87 | 128 | 9547 | 458 | 119 | 3.67 | 109.74 | 31.29 | |
25 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.979 Q2 | 63 | 38 | 98 | 3241 | 320 | 97 | 3.23 | 85.29 | 32.08 | |
26 | Journal of Immunology Research | journal | 0.979 Q1 | 113 | 55 | 49 | 4332 | 179 | 49 | 2.84 | 78.76 | 36.21 | |
27 | Current Neurovascular Research | journal | 0.968 Q2 | 60 | 32 | 99 | 2149 | 351 | 97 | 3.27 | 67.16 | 44.31 | |
28 | Current Drug Discovery Technologies | journal | 0.956 Q2 | 49 | 29 | 93 | 2418 | 295 | 90 | 3.50 | 83.38 | 28.57 | |
29 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q1 | 107 | 107 | 402 | 10462 | 1269 | 401 | 2.93 | 97.78 | 40.43 | |
30 | Mini-Reviews in Organic Chemistry | journal | 0.920 Q2 | 43 | 30 | 93 | 2629 | 215 | 93 | 2.36 | 87.63 | 29.90 | |
31 | Recent Patents on CNS Drug Discovery | journal | 0.886 Q2 | 36 | 22 | 64 | 2758 | 190 | 64 | 2.88 | 125.36 | 41.43 | |
32 | Infectious Disorders - Drug Targets | journal | 0.876 Q1 | 61 | 44 | 122 | 3794 | 309 | 107 | 2.28 | 86.23 | 37.62 | |
33 | Reviews on Recent Clinical Trials | journal | 0.858 Q1 | 35 | 23 | 80 | 1543 | 201 | 76 | 2.29 | 67.09 | 32.39 | |
34 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.842 Q1 | 43 | 20 | 100 | 1852 | 268 | 99 | 2.86 | 92.60 | 47.50 | |
35 | Combinatorial Chemistry and High Throughput Screening | journal | 0.822 Q1 | 70 | 99 | 271 | 5804 | 677 | 243 | 2.63 | 58.63 | 31.08 | |
36 | Journal of Function Spaces | journal | 0.812 Q2 | 37 | 15 | 34 | 258 | 25 | 34 | 0.74 | 17.20 | 41.67 | |
37 | Canadian Respiratory Journal | journal | 0.744 Q2 | 63 | 64 | 205 | 1403 | 267 | 152 | 1.10 | 21.92 | 32.64 | |
38 | Current Clinical Pharmacology | journal | 0.732 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
39 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.705 Q2 | 45 | 34 | 95 | 3265 | 206 | 93 | 1.95 | 96.03 | 34.95 | |
40 | Current Molecular Pharmacology | journal | 0.690 Q2 | 49 | 14 | 50 | 1728 | 117 | 50 | 2.34 | 123.43 | 26.19 | |
41 | Current Drug Delivery | journal | 0.673 Q1 | 72 | 51 | 144 | 1910 | 394 | 143 | 1.81 | 37.45 | 31.45 | |
42 | Science and Technology of Nuclear Installations | journal | 0.663 Q1 | 29 | 17 | 87 | 280 | 74 | 81 | 0.85 | 16.47 | 10.00 | |
43 | Recent Patents on Drug Delivery and Formulation | journal | 0.645 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
44 | Canadian Journal of Gastroenterology and Hepatology | journal | 0.625 Q2 | 76 | 89 | 349 | 2231 | 543 | 294 | 1.50 | 25.07 | 32.53 | |
45 | Current Analytical Chemistry | journal | 0.620 Q2 | 38 | 42 | 94 | 1533 | 170 | 91 | 1.77 | 36.50 | 43.75 | |
46 | Open Chemical Engineering Journal | journal | 0.619 Q1 | 15 | 8 | 6 | 339 | 10 | 6 | 1.67 | 42.38 | 28.57 | |
47 | Current Nanoscience | journal | 0.610 Q1 | 52 | 88 | 163 | 4067 | 335 | 162 | 2.13 | 46.22 | 32.57 | |
48 | Clinical Practice and Epidemiology in Mental Health | journal | 0.607 Q2 | 58 | 19 | 80 | 838 | 169 | 79 | 1.90 | 44.11 | 43.40 | |
49 | Turkish Journal of Earth Sciences | journal | 0.605 Q1 | 50 | 38 | 90 | 2387 | 125 | 88 | 1.06 | 62.82 | 29.70 | |
50 | International Journal of Telemedicine and Applications | journal | 0.595 Q2 | 35 | 14 | 35 | 446 | 79 | 33 | 2.26 | 31.86 | 24.32 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®